Genetic and pharmacological inhibition of GITR‐GITRL interaction reduces chronic lung injury induced by bleomycin instillation
暂无分享,去创建一个
E. Mazzon | S. Cuzzocrea | C. Riccardi | T. Genovese | R. Di Paola | C. Muià | E. Esposito | M. Agostini | G. Nocentini | S. Ronchetti
[1] E. Mazzon,et al. Proinflammatory Role of Glucocorticoid-Induced TNF Receptor-Related Gene in Acute Lung Inflammation1 , 2006, The Journal of Immunology.
[2] R. Arch,et al. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. , 2006, Frontiers in bioscience : a journal and virtual library.
[3] Antje Prasse,et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. , 2006, American journal of respiratory and critical care medicine.
[4] C. Riccardi,et al. The Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Gene Modulates the Response to Candida albicans Infection , 2005, Infection and Immunity.
[5] T. Nomura,et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells , 2005, The Journal of experimental medicine.
[6] B. Rouse,et al. In Vivo Kinetics of GITR and GITR Ligand Expression and Their Functional Significance in Regulating Viral Immunopathology , 2005, Journal of Virology.
[7] E. Mazzon,et al. Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] E. Mazzon,et al. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice , 2005, Respiratory research.
[9] Hye-Seon Choi,et al. Soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) stimulates osteoclast differentiation in response to receptor activator of NF-κB ligand (RANKL) in osteoclast cells , 2005 .
[10] C. Riccardi,et al. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily , 2005, European journal of immunology.
[11] K. Wu. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.
[12] T. Hirata,et al. Rolling of Th1 Cells via P-Selectin Glycoprotein Ligand-1 Stimulates LFA-1-Mediated Cell Binding to ICAM-11 , 2005, The Journal of Immunology.
[13] E. Mazzon,et al. Glucocorticoid‐induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock , 2004, Journal of leukocyte biology.
[14] I. Verma,et al. Nuclear factor (NF)-κB proteins: therapeutic targets* , 2004 .
[15] D. Lefer,et al. Leukocyte and endothelial adhesion molecule studies in knockout mice. , 2004, Current opinion in pharmacology.
[16] C. Riccardi,et al. Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations , 2004, European journal of immunology.
[17] B. Kwon,et al. Cloning and characterization of GITR ligand , 2003, Genes and Immunity.
[18] H. Waldmann,et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Song,et al. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. , 2003, Biochemical and biophysical research communications.
[20] B. Kwon,et al. Soluble glucocorticoid‐induced tumor necrosis factor receptor (sGITR) increased MMP‐9 activity in murine macrophage , 2003, Journal of cellular biochemistry.
[21] F. Green. Overview of pulmonary fibrosis. , 2002, Chest.
[22] M. Selman,et al. Molecular mechanisms of pulmonary fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.
[23] P. Pandolfi,et al. Role of GITR in activation response of T lymphocytes. , 2002, Blood.
[24] R. Bowler,et al. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[25] Y. Lee,et al. Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage , 2002, FEBS letters.
[26] J. Shimizu,et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.
[27] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[28] T. Oury,et al. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. , 2001, American journal of respiratory cell and molecular biology.
[29] Y. Nomura. NF-κB activation and IκBα dynamism involved in iNOS and chemokine induction in astroglial cells , 2001 .
[30] Guo-liang Yu,et al. Identification of a Novel Activation-inducible Protein of the Tumor Necrosis Factor Receptor Superfamily and Its Ligand* , 1999, The Journal of Biological Chemistry.
[31] A. Gurney,et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR , 1999, Current Biology.
[32] J. Myers,et al. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.
[33] C. Riccardi,et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Swensen,et al. Colchicine versus prednisone as treatment of usual interstitial pneumonia. , 1997, Mayo Clinic proceedings.
[35] J. Samet,et al. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. , 1996, Chest.
[36] K. Yamauchi,et al. Co‐expression of TNFα and IL‐1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysis , 1996 .
[37] A. Fine,et al. Potential therapeutic initiatives for fibrogenic lung diseases. , 1995, Chest.
[38] J. Kelley,et al. Variable expression of platelet-derived growth factor family proteins in acute lung injury. , 1993, American journal of respiratory cell and molecular biology.
[39] G. Raghu,et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. , 1991, The American review of respiratory disease.
[40] A. Lazenby,et al. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. , 1990, The American review of respiratory disease.
[41] J. Darbyshire,et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.
[42] J M Simpson,et al. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.
[43] K. Mullane,et al. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. , 1985, Journal of pharmacological methods.
[44] D. Hyde,et al. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. , 1983, The American journal of pathology.
[45] M. Merville,et al. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .
[46] M. Merville,et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. , 2005, Trends in biochemical sciences.
[47] I. Verma. Nuclear factor (NF)-kappaB proteins: therapeutic targets. , 2004, Annals of the rheumatic diseases.
[48] Y. Nomura. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. , 2001, Life sciences.
[49] Arnold Simanowitz,et al. international consensus statement , 2000 .
[50] David A. Lynch,et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .
[51] American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). , 2000, American journal of respiratory and critical care medicine.
[52] K. Yamauchi,et al. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. , 1996, Pathology international.
[53] M. Kris,et al. Acute chest pain syndrome during bleomycin infusions. , 1987, Cancer.